Agilent Technologies, Inc. (A) Quick Ratio (Acid-Test): 1.52
Is Agilent Technologies, Inc.’s quick ratio (acid-test) high or low?
Agilent Technologies, Inc.'s quick ratio (acid-test) of 1.52 is in line with its 5-year average of 1.68, near the low end of its 5-year range (1.47–1.97).
The quick ratio (acid-test) for Agilent Technologies, Inc. (A) is 1.52 as of Wednesday, June 10, 2026. It is below its 12-month average by 1.62% (1.54).
A Quick Ratio (Acid-Test) Chart
A Average Quick Ratio (Acid-Test) Chart
A Current vs Average Quick Ratio (Acid-Test) Chart
A Quick Ratio (Acid-Test) Metrics
QUICK RATIO (ACID-TEST)
1.52
QUICK RATIO (ACID-TEST) AVG TTM
1.54
QUICK RATIO (ACID-TEST) AVG 3Y
1.63
QUICK RATIO (ACID-TEST) AVG 5Y
1.68
QUICK RATIO (ACID-TEST) AVG 10Y
2.13
QUICK RATIO (ACID-TEST) AVG 15Y
2.19
QUICK RATIO (ACID-TEST) AVG 20Y
2.19
CURRENT VS TTM AVG
-1.62%
CURRENT VS 3Y AVG
-6.89%
CURRENT VS 5Y AVG
-9.79%
CURRENT VS 10Y AVG
-28.58%
CURRENT VS 15Y AVG
-30.51%
CURRENT VS 20Y AVG
-30.49%
A Competitors' Quick Ratio (Acid-Test)
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Agilent Technologies, Inc. (A) | — | 1.52 | 1.54 | 1.63 | 1.68 |
| Zoetis Inc. (ZTS) | $34.20B | 1.94 | 1.51 | 1.66 | 1.96 |
| Centene Corporation (CNC) | $31.94B | 1.68 | 1.40 | 1.24 | 1.19 |
| Medline Inc. (MDLN) | $30.90B | 2.37 | 1.97 | 2.09 | 2.09 |
| IQVIA Holdings Inc. (IQV) | $30.60B | 0.75 | 0.79 | 0.83 | 0.90 |
| Humana Inc. (HUM) | $43.78B | 0.72 | 0.58 | 0.57 | 0.58 |
| IDEXX Laboratories, Inc. (IDXX) | $44.47B | 0.84 | 0.90 | 0.89 | 0.98 |
| DexCom, Inc. (DXCM) | $29.24B | 1.59 | 1.44 | 1.80 | 2.83 |
| Biogen Inc. (BIIB) | $29.00B | 2.03 | 1.46 | 1.69 | 1.64 |
| Veeva Systems Inc. (VEEV) | $26.73B | 4.89 | 4.70 | 4.39 | 4.08 |
Liquidity Comparison
Quick Ratio
1.52
Excludes inventory
Current Ratio
1.96
Includes inventory
Agilent Technologies, Inc. Quick Ratio (Acid-Test) Formula & Definition
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Agilent Technologies, Inc. Quick Ratio (Acid-Test) FAQ
- What is the quick ratio (acid-test) for Agilent Technologies, Inc. (A)?
- The quick ratio (acid-test) for A stock is 1.52.
- Is Agilent Technologies, Inc.'s quick ratio (acid-test) high or low?
- Agilent Technologies, Inc.'s quick ratio (acid-test) of 1.52 is in line with its 5-year average of 1.68, near the low end of its 5-year range (1.47–1.97).
- What is the TTM average quick ratio (acid-test) for Agilent Technologies, Inc. (A)?
- The TTM average quick ratio (acid-test) for A stock is 1.54.
- What is the 3Y average quick ratio (acid-test) for Agilent Technologies, Inc. (A)?
- The 3Y average quick ratio (acid-test) for A stock is 1.63.
- What is the 5Y average quick ratio (acid-test) for Agilent Technologies, Inc. (A)?
- The 5Y average quick ratio (acid-test) for A stock is 1.68.
- What is the 10Y average quick ratio (acid-test) for Agilent Technologies, Inc. (A)?
- The 10Y average quick ratio (acid-test) for A stock is 2.13.
- What is the 15Y average quick ratio (acid-test) for Agilent Technologies, Inc. (A)?
- The 15Y average quick ratio (acid-test) for A stock is 2.19.
- What is the 20Y average quick ratio (acid-test) for Agilent Technologies, Inc. (A)?
- The 20Y average quick ratio (acid-test) for A stock is 2.19.
Agilent Technologies, Inc. Quick Ratio (Acid-Test) History
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2025-10-31 | 1.52 |
| 2024-10-31 | 1.57 |
| 2023-10-31 | 1.97 |
| 2022-10-31 | 1.47 |
| 2021-10-31 | 1.74 |
| 2020-10-31 | 1.84 |
| 2019-10-31 | 1.21 |
| 2018-10-31 | 2.74 |
| 2017-10-31 | 2.85 |
| 2016-10-31 | 3.28 |
| 2015-10-31 | 3.22 |
| 2014-10-31 | 2.92 |
| 2013-10-31 | 2.45 |
| 2012-10-31 | 1.91 |
| 2011-10-31 | 2.54 |
| 2010-10-31 | 1.77 |
| 2009-10-31 | 3.04 |
| 2008-10-31 | 1.91 |
| 2007-10-31 | 1.82 |
| 2006-10-31 | 2.17 |
| 2005-10-31 | 1.98 |
| 2004-10-31 | 2.17 |
| 2003-10-31 | 1.52 |
| 2002-10-31 | 1.69 |
| 2001-10-31 | 1.65 |
| 2000-10-31 | 1.23 |
| 1999-10-31 | 1.21 |
| 1998-10-31 | 0.99 |
Related Metrics
About Agilent Technologies, Inc.
Agilent Technologies, Inc. delivers specialized, application-focused technologies and services to the global life sciences, diagnostics, and applied chemistry industries. Its Life Sciences and Applied Markets segment provides a comprehensive portfolio of analytical instrumentation. This includes liquid chromatography (LC) and gas chromatography (GC) systems, often integrated with mass spectrometry (MS) for advanced analysis (LC-MS, GC-MS). They also offer inductively coupled plasma mass spectrometry (ICP-MS), atomic absorption (AA), microwave plasma-atomic emission spectrometry (MP-AES), and inductively coupled plasma optical emission spectrometry (ICP-OES) instruments, alongside Raman spectroscopy for material characterization. Beyond spectroscopy, the segment supplies cell analysis solutions such as plate-based assays, flow cytometers, real-time cell analyzers, imaging systems, and microplate readers. Complementing these are various laboratory software, information management platforms, data analytics tools, automated and robotic lab systems, dissolution testing equipment, vacuum technology, and general measurement solutions. The Diagnostics and Genomics division offers cutting-edge tools for genetic and diagnostic research. These encompass arrays designed for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression analysis. This segment also provides target enrichment solutions for next-generation sequencing, along with software for genetic data management and interpretation. Furthermore, it synthesizes custom oligonucleotides. Other significant offerings include immunohistochemistry (IHC), in situ hybridization (ISH), hematoxylin and eosin (H&E) staining, and specialized staining solutions. The division also supplies consumables and software essential for quality control analysis of nucleic acid samples, as well as reagents for turbidimetry and flow cytometry applications. A key area of development for this segment is liquid-based pharmacodiagnostics. Agilent CrossLab, the third segment, focuses on providing essential laboratory consumables and services. Its product range features GC and LC columns, products for sample preparation, custom chemical formulations, and various supplies for laboratory instruments. Complementary services include expert support for startup, ongoing operations, training, compliance, Software-as-a-Service (SaaS) offerings, asset management, and professional consultation. The company's products reach customers through a diverse sales network, including direct sales teams, distributors, resellers, manufacturer's representatives, and its e-commerce platforms. Agilent Technologies, Inc. was established in 1999 and maintains its corporate headquarters in Santa Clara, California.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Padraig McDonnell